5-Bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one targets prostate cancer cells by down-regulating inflammation-related genes. (2016). Bangladesh Journal of Pharmacology, 11(2), 408-413. https://doi.org/10.3329/bjp.v11i2.23872